0001567619-20-016342.txt : 20200902
0001567619-20-016342.hdr.sgml : 20200902
20200902170023
ACCESSION NUMBER: 0001567619-20-016342
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200831
FILED AS OF DATE: 20200902
DATE AS OF CHANGE: 20200902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TWIGGE GIOVANI
CENTRAL INDEX KEY: 0001500399
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 201157485
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2020-08-31
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001500399
TWIGGE GIOVANI
IDEXX LABORATORIES, INC.
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
CORPORATE VICE PRESIDENT
Common Stock
2020-08-31
4
M
0
1316
79.54
A
14222
D
Common Stock
2020-08-31
4
M
0
6000
67.85
A
20222
D
Common Stock
2020-08-31
4
S
0
3243
387.3276
D
16979
D
Common Stock
2020-08-31
4
S
0
2788
388.7918
D
14191
D
Common Stock
2020-08-31
4
S
0
1285
389.0779
D
12906
D
Non-Qualified Stock Option (right-to-buy)
79.54
2020-08-31
4
M
0
1316
D
2025-02-13
Common Stock
1316
0
D
Non-Qualified Stock Option (right-to-buy)
67.85
2020-08-31
4
M
0
6000
D
2026-02-13
Common Stock
6000
16028
D
Represents the weighted average price of the shares sold ranging from a low of $387.00 to a high of $387.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $388.01 to a high of $389.01 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $389.02 to a high of $389.16 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 9,677 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 22,028 shares of IDEXX Laboratories, Inc. common stock that vests in five annual installments beginning February 14, 2017.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Giovani Twigge
2020-09-02